AIXN — AiXin Life International, Inc.

OTC · Consumer Staples · Drug Retail · CIK 835662 ·
Last close
$0.32
Market Cap
$8.00M
52W High
$0.65
52W Low
$0.17
ADV30
103
Next earnings
AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. It operates through Direct Sales, Pharmacy, Hotel, and Manufacture and Sale segments. The company provides herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat's milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. It also engages in hotel business. The company provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. It sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. AiXin Life International, Inc. is based in Chengdu, China.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 327,688 -86,404 -680,232 -628,789 3,200,974 20,751 9,769,725
Sep 2025 301,979 -105,412 -347,209 -340,461 3,372,467 19,113 9,196,866
Jun 2025 460,929 -84,128 -810,624 -351,505 3,346,709 29,621 8,796,650
Mar 2025 398,831 -184,988 -682,485 -721,708 4,050,474 63,109 9,081,278

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-2,034,331
Investing CF
$-13,045
Financing CF
$1,994,344
CapEx
$-9,550
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.08
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-22,031,196
Inventory
$427,426
Receivables
$498,852
ST Investments
EBIT TTM
$-2,486,756
Pretax Income TTM
$-2,042,072
Interest Exp TTM
$14,663
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,489,427
EBITDA
$-2,365,593
Free Cash Flow
$-188,715
Enterprise Value
$9,472,718
Total Cash
$73,143
Total Debt
$1,548,414
Shares Out
24,999,834
Trailing EPS
$-0.08
Book Value
$-0.26
ROE
ROA
-41.4%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,489,427 -2,520,550 -2,042,463 3,200,974 9,769,725 -2,034,331
Dec 2024 3,824,301 -2,588,191 -2,768,341 4,406,360 8,688,763 -1,628,834
Dec 2023 4,089,799 -2,498,807 -2,090,694 4,842,358 6,753,939 -1,392,259
Dec 2022 2,708,560 -2,569,459 -6,369,245 5,050,884 5,517,072 -1,624,565
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
YI 111, Inc. $25.41M $4.89
PETS PETMED EXPRESS INC $39.53M $1.85
RDGT Ridgetech Inc. $1.29M $1.43
GRDN Guardian Pharmacy Services, Inc. $2.15B $43.09
CVS CVS HEALTH Corp $130.09B $101.96

Recent Insider Activity

No insider activity indexed for this ticker.